PSNC submits evidence to generic medicines inquiry by MPs

PSNC submits evidence to generic medicines inquiry by MPs

July 3, 2018

PSNC has provided written evidence to an inquiry into price increases seen in the generic medicines market.

Following the National Audit Office investigation into NHS spending on generic medicines in primary care, the Public Accounts Committee decided to conduct an inquiry. The committee of MPs, responsible for overseeing government expenditures, invited stakeholders to provide information on their experiences of price fluctuations and how this is affecting the supply of vital medicines to patients.

PSNC’s submission seeks to ensure improvements for the future whilst emphasising the added pressures that community pharmacy teams have faced. The written evidence also includes details of the issues pharmacy contractors have experienced in this area, plus recommendations for a new Price Concessions system.

Read PSNC’s written submission in full.

Learn more about the inquiry.

PSNC Director of Pharmacy Funding, Mike Dent, said:

“PSNC welcomed the opportunity to submit evidence to the Public Accounts Committee and hopes the inquiry will help determine how best to stabilise the generics market in order to protect patients from harm. Community pharmacy teams have been going above and beyond to obtain medicines in a timely manner during this period of unprecedented price increases and we hope this hard work is recognised. With new powers to request information on prices effective from next month, we now look to the Department of Health and Social Care to make progress in line with the principles we have shared with them.”



Posted in: , ,


More Latest News >